Vanguard disaggregates holdings; ALAB ownership listed as 0% (ALAB)
Rhea-AI Filing Summary
Astera Labs Inc Schedule 13G/A amendment: The Vanguard Group reports zero beneficial ownership of Astera Labs common stock following an internal realignment that disaggregated certain subsidiaries' holdings, in accordance with SEC Release No. 34-39538.
The filing states Vanguard’s subsidiaries will report beneficial ownership separately and that Vanguard no longer is deemed to beneficially own the shares previously reported by those units.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings; reporting entity shows no ownership.
The amendment records 0 shares and 0% ownership, citing an internal realignment and reliance on SEC Release No. 34-39538. This reflects a reporting change where subsidiaries now file separately rather than a market trade.
Cash‑flow treatment and any subsidiary-level holdings are not included in this amendment; subsequent filings by the relevant Vanguard subsidiaries would show actual positions.
Amendment clarifies reporting structure, not a transactional disposition.
The statement explains an internal realignment effective January 12, 2026
and reliance on the specified SEC release to disaggregate beneficial ownership. The practical effect is administrative: ownership will be reported by separate Vanguard entities going forward.
FAQ
What does The Vanguard Group report for Astera Labs (ALAB)?
Why does Vanguard say it has zero ownership of ALAB?
Does this filing mean Vanguard sold ALAB shares?
Who signed the Schedule 13G/A for Vanguard?
Will Vanguard subsidiaries now file separate ownership reports for ALAB?